tafasitamab

A drug used with lenalidomide to treat adults with certain types of diffuse large B-cell lymphoma that relapsed (came back) or did not get better after treatment with other anticancer therapy. It is used in patients who cannot be treated with an autologous stem cell transplant. It is also being studied in the treatment of other types of cancer. Tafasitamab binds to a protein called CD19, which is found on most B cells (a type of white blood cell) and some lymphoma cells. This may help the immune system kill cancer cells. Tafasitamab is a type of monoclonal antibody. Also called Monjuvi.